Trial intelligence / Profile preview

Tapentadol oral solution for post-surgical pain in children and adolescents

2013-002016-27Phase 2

Sponsor
Grünenthal GmbH
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of tapentadol in postoperative pain, sponsored by Grünenthal GmbH. Primary endpoint: Pharmacokinetic profile of tapentadol and tapentadol-O-glucuronide.

02

Drugs

tapentadol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2013-002016-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-002016-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call